1. Home
  2. GDTC vs ZCMD Comparison

GDTC vs ZCMD Comparison

Compare GDTC & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • ZCMD
  • Stock Information
  • Founded
  • GDTC 2018
  • ZCMD 2012
  • Country
  • GDTC Singapore
  • ZCMD China
  • Employees
  • GDTC N/A
  • ZCMD N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • ZCMD Other Consumer Services
  • Sector
  • GDTC Health Care
  • ZCMD Real Estate
  • Exchange
  • GDTC Nasdaq
  • ZCMD Nasdaq
  • Market Cap
  • GDTC 28.0M
  • ZCMD 28.5M
  • IPO Year
  • GDTC 2023
  • ZCMD 2020
  • Fundamental
  • Price
  • GDTC $1.86
  • ZCMD $1.05
  • Analyst Decision
  • GDTC Buy
  • ZCMD
  • Analyst Count
  • GDTC 1
  • ZCMD 0
  • Target Price
  • GDTC $5.00
  • ZCMD N/A
  • AVG Volume (30 Days)
  • GDTC 10.3K
  • ZCMD 158.9K
  • Earning Date
  • GDTC 01-01-0001
  • ZCMD 01-01-0001
  • Dividend Yield
  • GDTC N/A
  • ZCMD N/A
  • EPS Growth
  • GDTC N/A
  • ZCMD N/A
  • EPS
  • GDTC N/A
  • ZCMD N/A
  • Revenue
  • GDTC $368,838.00
  • ZCMD $15,864,773.00
  • Revenue This Year
  • GDTC $5.37
  • ZCMD N/A
  • Revenue Next Year
  • GDTC N/A
  • ZCMD N/A
  • P/E Ratio
  • GDTC N/A
  • ZCMD N/A
  • Revenue Growth
  • GDTC N/A
  • ZCMD N/A
  • 52 Week Low
  • GDTC $1.20
  • ZCMD $0.95
  • 52 Week High
  • GDTC $4.05
  • ZCMD $2.97
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 41.07
  • ZCMD 42.02
  • Support Level
  • GDTC $1.96
  • ZCMD $1.10
  • Resistance Level
  • GDTC $2.26
  • ZCMD $1.24
  • Average True Range (ATR)
  • GDTC 0.10
  • ZCMD 0.06
  • MACD
  • GDTC -0.02
  • ZCMD -0.01
  • Stochastic Oscillator
  • GDTC 17.95
  • ZCMD 13.64

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.

Share on Social Networks: